These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36059855)

  • 1. Perceived risks of transit use during COVID-19: Correlates and strategies from a case study in El Paso, Texas.
    Bian JJ; Zhong S; Towne SD; Lee C; Ory MG; Li W
    J Transp Health; 2022 Dec; 27():101491. PubMed ID: 36059855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness, perceptions and challenges among public transport operators during the implementation of COVID-19 preventive measures in eastern Uganda: a qualitative study.
    Napyo A; Hopp L; Mukunya D; Soita D; Matovu JK
    Res Sq; 2023 Oct; ():. PubMed ID: 37886460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covid-19 pandemic impacts on essential transit riders: Findings from a U.S. Survey.
    He Q; Rowangould D; Karner A; Palm M; LaRue S
    Transp Res D Transp Environ; 2022 Apr; 105():103217. PubMed ID: 35194378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-Ridership: A web tool for reprogramming public transportation fleets to minimize COVID-19 transmission.
    Imani S; Vahed M; Satodia S; Vahed M
    SoftwareX; 2023 May; 22():101350. PubMed ID: 36969748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transit communication via Twitter during the COVID-19 pandemic.
    Zhang W; Barchers C; Smith-Colin J
    Environ Plan B Urban Anal City Sci; 2023 Jun; 50(5):1244-1261. PubMed ID: 38603201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The uneven impacts of avoiding public transit on riders' access to healthcare during COVID-19.
    Palm M; Sturrock SL; Howell NA; Farber S; Widener MJ
    J Transp Health; 2021 Sep; 22():101112. PubMed ID: 36570715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 on Public Transit Accessibility and Ridership.
    Wilbur M; Ayman A; Sivagnanam A; Ouyang A; Poon V; Kabir R; Vadali A; Pugliese P; Freudberg D; Laszka A; Dubey A
    Transp Res Rec; 2023 Apr; 2677(4):531-546. PubMed ID: 38602901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring the well-being of vulnerable transit riders using machine learning based sentiment analysis and social media: Lessons from COVID-19.
    Tran M; Draeger C; Wang X; Nikbakht A
    Environ Plan B Urban Anal City Sci; 2023 Jan; 50(1):60-75. PubMed ID: 38603239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An estimation of the effects of social distancing measures on transit vehicle capacity and operations.
    Kamga C; Tchamna R; Vicuna P; Mudigonda S; Moghimi B
    Transp Res Interdiscip Perspect; 2021 Jun; 10():100398. PubMed ID: 34514373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public transit use in the United States in the era of COVID-19: Transit riders' travel behavior in the COVID-19 impact and recovery period.
    Parker MEG; Li M; Bouzaghrane MA; Obeid H; Hayes D; Frick KT; Rodríguez DA; Sengupta R; Walker J; Chatman DG
    Transp Policy (Oxf); 2021 Sep; 111():53-62. PubMed ID: 36568351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the subway attraction for the post-COVID-19 era: The role of fare-free public transport policy.
    Dai J; Liu Z; Li R
    Transp Policy (Oxf); 2021 Mar; 103():21-30. PubMed ID: 36570709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slowing the spread of COVID-19: Review of "Social distancing" interventions deployed by public transit in the United States and Canada.
    Kamga C; Eickemeyer P
    Transp Policy (Oxf); 2021 Jun; 106():25-36. PubMed ID: 33814735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities in the Impacts of the COVID-19 Pandemic on Public Transit Ridership in Austin, Texas, U.S.A.
    Jiao J; Hansen K; Azimian A
    Transp Res Rec; 2023 Apr; 2677(4):287-297. PubMed ID: 37153206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived risk of using shared mobility services during the COVID-19 pandemic.
    Rahimi E; Shabanpour R; Shamshiripour A; Kouros Mohammadian A
    Transp Res Part F Traffic Psychol Behav; 2021 Aug; 81():271-281. PubMed ID: 36567796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating public transit agency responses to the Covid-19 pandemic in seven U.S. regions.
    Karner A; LaRue S; Klumpenhouwer W; Rowangould D
    Case Stud Transp Policy; 2023 Jun; 12():100989. PubMed ID: 36910544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facing the future of transit ridership: shifting attitudes towards public transit and auto ownership among transit riders during COVID-19.
    Palm M; Allen J; Zhang Y; Tiznado-Aitken I; Batomen B; Farber S; Widener M
    Transportation (Amst); 2022 Oct; ():1-27. PubMed ID: 36340501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of COVID-19 on Transit Workers: Perceptions of Employer Responses and Associations with Health Factors.
    Rice SPM; Greenspan LS; Bauer TN; Rimby J; Bodner TE; Olson R
    Ann Work Expo Health; 2022 Mar; 66(3):334-347. PubMed ID: 34623393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TROLLEY Study: assessing travel, health, and equity impacts of a new light rail transit investment during the COVID-19 pandemic.
    Crist K; Benmarhnia T; Frank LD; Song D; Zunshine E; Sallis JF
    BMC Public Health; 2022 Aug; 22(1):1475. PubMed ID: 35918683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public transit and crisis communication for critical populations: A content analysis of web-based communication strategies during the COVID-19 pandemic.
    Franks JL; Thomas EV
    J Emerg Manag; 2024; 22(2):195-212. PubMed ID: 38695715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A latent class analysis to understand riders' adoption of on-demand mobility services as a complement to transit.
    Wang Y; Shen Q
    Transportation (Amst); 2022 Dec; ():1-19. PubMed ID: 36530965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.